Skip to main content
SpringerLink
Log in

The Molecular Basis of Breast Carcinogenesis

  • Chapter
The Molecular Basis of Human Cancer

Abstract

Breast cancer is the most common malignancy affecting women today. This disease has reached epidemic proportions in the industrialized world, afflicting as many as one in eight women (1), and causing approx 45,000 deaths per year (2,3). In response to this major public health problem, research funding is being used to identify key steps in breast carcinogenesis with the goal of developing effective means for preventing, diagnosing, and treating this devastating disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 209.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Feuer, E., Wun L., Boring C., Flanders W., Timmel M., and Tong T. (1993) The lifetime risk of developing breast cancer. J. Natl. Cancer Inst. 85: 892–897.

    Article  PubMed  CAS  Google Scholar 

  2. Kelsey., J. and Horn-Ross, P. (1993) Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol. Rev. 15: 716.

    Google Scholar 

  3. Wingo, P. A., Tong R., and Bolden, S. (1995) Cancer Statistics, 1995. Ca: Cancer J. Clin. 45: 8–30.

    Article  CAS  Google Scholar 

  4. Pike, M., Spicer, D., Dahmoush, L., and Press, M. (1993) Estrogens, progesterones, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev. 15: 17.

    PubMed  CAS  Google Scholar 

  5. McGregor, H., Land, C., Choi, K., Tokuoka, S., Liu, P., Wakabayashi, T., and Beebe, C. (1977) Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 19601969. J. Natl. Cancer Inst. 59: 799–811.

    PubMed  CAS  Google Scholar 

  6. Bhatia, S., Robison, L., Oberlin, O., Greenberg, M., Bunin, G., Fossati-Bellani, F., et al. (1996) Breast cancer and other second neoplasms after childhood Hodgkin’s disease. N. Engl. J. Med. 334: 74: 5–751.

    Google Scholar 

  7. el-Bayoumy, K. (1992) Environmental carcinogens that may be involved in human breast cancer etiology. Chem. Res. Toxicol. 5: 585–590.

    Article  PubMed  CAS  Google Scholar 

  8. Wolff, M. and Weston, A. (1997) Breast cancer risk and environmental exposures. Environ. Health Perspect. 4: 891–896.

    Google Scholar 

  9. Russo, J., Rivera, R., and Russo, I. (1992) Influence of age and parity on the development of the human breast. Breast Cancer Res. Treat. 23: 211–218.

    Article  PubMed  CAS  Google Scholar 

  10. Wellings, S., Jensen, H., and Marcum, R. (1975) An atlas of subgross pathology of 16 human breasts with special reference to possible precancerous lesions. J. Natl. Cancer Inst. 55: 231–275.

    PubMed  CAS  Google Scholar 

  11. Rosen, P. P. (1979) The pathological classification of human mammary carcinoma: past, present and future. Ann. Clin. Lab. Sci. 9: 144–156.

    PubMed  CAS  Google Scholar 

  12. Tavassoli, F. (1992) Pathology of the Breast. Appleton and Lange, Norwalk, CT.

    Google Scholar 

  13. Silverstein, M., Lewinsky, B., Waisman, J., Gierson, E., Colburn, W., Senofsky, G., et al. (1994) Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer 73: 1673–1677.

    Article  PubMed  CAS  Google Scholar 

  14. Dixon, J. M., Anderson, T. J., Page, D. L., Lee, D., Duffy, S. W., and Stewart, H. J. (1983) Infiltrating lobular carcinoma of the breast: an evaluation of the incidence and consequence of bilateral disease. Br. J. Surg. 70: 513–516.

    Article  PubMed  CAS  Google Scholar 

  15. Ponten, J., Holmberg, L., Trichopoulos, D., Kallioniemi, O., Kvale, G., Wallgren, A., et al. (1990) Biology and natural history of breast cancer. Int. J. Cancer 5: 5–21.

    Article  CAS  Google Scholar 

  16. Alpers, C. and Wellings, S. (1985) The prevalence of carcinoma in situ in normal and cancer-associated breasts. Human Pathol. 16: 796–807.

    Article  CAS  Google Scholar 

  17. Dupont, W. and Page, D. (1985) Risk factors for breast cancer in women with proliferative breast disease. N. Engl. J. Med. 312: 146–151.

    Article  PubMed  CAS  Google Scholar 

  18. Solin, L., Recht, A., Kurtz, J., Kuske, R., McNeese, M., McCormick, B., et al. (1991) Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast. Cancer 68: 2337–2344.

    Article  PubMed  CAS  Google Scholar 

  19. Lakhani, S. R., Collins, N., Sloane, J. P., and Stratton, M. R. (1995) Loss of heterozygosity in lobular carcinoma in situ of the breast. J. Clin. Pathol. 48: M74 - M78.

    Article  CAS  Google Scholar 

  20. Page, D. and Dupont, W. (1992) Benign breast disease: indicators of increased breast cancer risk. Cancer Detect. Prevent. 16: 93–97.

    PubMed  CAS  Google Scholar 

  21. Newman, B., Austin, M., Lee, M., and King, M.-C. (1988) Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc. Natl. Acad. Sci. USA 85: 3044–3048.

    Article  PubMed  CAS  Google Scholar 

  22. Claus, E. B., Risch, N., and Thompson, W. D. (1991) Genetic analysis of breast cancer in the cancer and steroid hormone study. Am. J. Human. Genet. 48: 232–242.

    CAS  Google Scholar 

  23. Anderson, D. (1991) Familial versus sporadic breast cancer. Cancer 70: 1740–1746.

    Article  Google Scholar 

  24. Liu, B., Parsons, R., Papadopoulos, N., Nicolaides, N. C., Lynch, H. T., Watson, P., et al. (1996) Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nature Med. 2: 169–174.

    Article  PubMed  CAS  Google Scholar 

  25. Kolodner, R., Hall,N., Lipford, J., Kane, M., Rao, M., Morrison, P., et al. (1994) Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for MSH2 mutations. Genomics 24: 516–526.

    Article  PubMed  CAS  Google Scholar 

  26. Bowcock, A. M., Anderson, L. A., Friedman, L. S., Black, D. M., Osborne-Lawrence, S., Rowell, S. E., et al. (1993) THRA 1 and DI75183 flank an interval of -4cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21. Am. J. Human Genet. 52: 718–722.

    CAS  Google Scholar 

  27. Chamberlain, J., Boehnke, M., Frank, T., Kiousis, S., Xu, J., Guo, S., et al. (1993) BRCA1 maps proximal to D17S579 on chromosome 17g21 by genetic analysis. Am. J. Human Genet. 52: 792–798.

    CAS  Google Scholar 

  28. Easton, D., Bishop, D., Ford, D., and Crockford, G. (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am. J. Human Genet. 52: 678–701.

    CAS  Google Scholar 

  29. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P., Harshman, K., Tavtigian, S., et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71.

    Article  PubMed  CAS  Google Scholar 

  30. Chapman, M. and Verma, I. (1996) Transcriptional activation by BRCA1. Nature 382: 678–679.

    Article  PubMed  CAS  Google Scholar 

  31. Cornelisse, C., Cornelis, R., and Devilee, P. (1996) Genes responsible for familial breast cancer. Pathol. Res. Practice 192: 684–693.

    Article  CAS  Google Scholar 

  32. Futreal, P., Söderkvist, P., Marks, J., Iglehart, J., Cochran, C., Barrett, J., et al. (1992) Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite lenght polymorphisms. Cancer Res. 52: 2624–2627.

    PubMed  CAS  Google Scholar 

  33. Cropp, C., Champeme, M.-H., Lidereau, R., and Callahan, R. (1993) Identification of three regions on chromosome I7q in primary human breast carcinomas which are frequently deleted. Cancer Res. 53: 5617–5619.

    PubMed  CAS  Google Scholar 

  34. Saito, H., Inazawa, J., Saito, S., Kasumi, F., Koi, S., Sagae, S., et al. (1993) Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17821.3 often and commonly deleted in tumors. Cancer Res. 53: 3382–3385.

    PubMed  CAS  Google Scholar 

  35. Devilee, P. and Cornelisse, C. (1990) Genetics of human breast cancer. Cancer Surv. 9: 605–630.

    PubMed  CAS  Google Scholar 

  36. Chen, Y., Chen, C., Riley, D., Allred, D., Chen, P., Von Hoff, D., et al. (1995) Aberrant subcellular localization of BRCA 1 in breast cancer. Science 270: 789–791.

    Article  PubMed  CAS  Google Scholar 

  37. Jensen, R., Thompson, M., Jetton, T., Szabo, C., van der Meer, R., Helou, B., et al. (1996) BRCAI is secreted and exhibits properties of a granin. Nature Genet. 12: 303–308.

    Article  PubMed  CAS  Google Scholar 

  38. Scully, R., Ganesan, S., Brown, M., DeCaprio, J., Cannistra, S., Feunteun, J., et al. (1996) Localization of BRCA I in human breast and ovarian cancer cells. Science 272: 122.

    Article  Google Scholar 

  39. Smith, S., Easton, D., Evans, D., and Ponder, B. (1992) Allele losses in the region 17q12-q21 in familial breast and ovarian cancer involve the wild-type chromosome. Nature Genet. 2: 128.

    Article  PubMed  CAS  Google Scholar 

  40. Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashely, T., et al. (1997) Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88: 265–275.

    Article  PubMed  CAS  Google Scholar 

  41. Chen, T., Sahin, A., and Aldaz, C. (1996) Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region. Cancer Res. 56: 5605–5609.

    PubMed  CAS  Google Scholar 

  42. Gowen, L., Avrutskaya, A., Latour, A., Koller, B., and Leadon, S. (1998) BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science 281: 1009–1012.

    Article  PubMed  CAS  Google Scholar 

  43. Wooster, R., Neuhausen, S., Mangion, J., Quirk, Y., Ford, D., Collins, N., et al. (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13. Science 265: 2088–2090.

    Article  PubMed  CAS  Google Scholar 

  44. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789–792.

    Article  PubMed  CAS  Google Scholar 

  45. Struewing, J., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M., Collins, F., et al. (1995) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet. 11: 198–200.

    Article  PubMed  CAS  Google Scholar 

  46. Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., et al. (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am. J. Human Genet. 62: 676–689.

    Article  CAS  Google Scholar 

  47. Malkin, D., Li, F., Strong, L., Fraumeni, J. J., Nelson, C., Kim, D., et al. (1990) Germline p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233–1238.

    Article  PubMed  CAS  Google Scholar 

  48. Srivastava, S., Zou, Z., Pirollo, K., Blattner, W., and Chang, E. (1990) Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348: 747–749.

    Article  PubMed  CAS  Google Scholar 

  49. Osborne, R., Merlo, G., Mitsudomi, T., Venesio, T., Liscia, D., Cappa, A., et al. (1991) Mutations in the p53 gene in primary human breast cancers. Cancer Res. 51: 6194–6198.

    PubMed  CAS  Google Scholar 

  50. Nelen, M., Padberg, G., Peeters, E., Lin, A., van den Helm, B., Frants, R., et al. (1996) Localization ofthe gene for Cowden disease to chromosome 10q22–23. Nature Genet. 13: 114–116.

    Article  PubMed  CAS  Google Scholar 

  51. Liaw, D., Marsh, D., Li, J., Dahia, P., Wang S., Zheng, Z., et al. (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet. 16: 64–67.

    Article  PubMed  CAS  Google Scholar 

  52. Steck, P., Pershouse, M., Jasser, S., Yung, W., Lin, H., Ligon, A., et al. (1997) Identification of a candidate tumour suppressor gene, MMACI, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet. 15: 356–362.

    Article  PubMed  CAS  Google Scholar 

  53. Li, J., Yen, C., Liaw, D., Podsypania, K., Bose, S., Wang, S., et al. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1876–1878.

    Article  Google Scholar 

  54. Cairns, P., Okami, K., Halachmi, S., Halachmi, N., Esteller, M., Herman, J., et al. (1997) Frequent inactivation of PTEN/MMACI in primary prostate cancer. Cancer Res. 57: 4997–5000.

    PubMed  CAS  Google Scholar 

  55. Risinger, J., Hayes, A., Berchuck, A., and Barrett, J. (1997) PTEN/ MMAC 1 mutations in endometrial cancers. Cancer Res. 57: 4736–4738.

    PubMed  CAS  Google Scholar 

  56. Rhei, E., Kang, L., Bogomolniy, F., Federici, M., Borgen, P., and Boyd, J. (1997) Mutation analysis of the putative tumor suppressor gene PTEN/MMAC I in primary breast carcinoma. Cancer Res. 57: 3657–3659.

    PubMed  CAS  Google Scholar 

  57. Ueda, K., Nishijima, M., Inui, H., Watatani, M., Yayoi, E., Okamura, J., et al. (1998) Infrequent mutations in the PTEN/ MMAC1 gene among primary breast cancers. Jpn. J. Cancer Res. 89: 17–21.

    Article  PubMed  CAS  Google Scholar 

  58. Gatti, R., Berkel, I., Boder, E., Braedt, G., Charmley, P., Concannon, P., et al. (1988) Localization of an ataxia-telangiectasia gene to chromosome 11g22–23. Nature 336: 577–580.

    Article  PubMed  CAS  Google Scholar 

  59. FitzGerald, M., Bean, J., Hegde, S., Unsal, H., MacDonald, D., Harkin, D., et al. (1997) Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nature Genet. 15: 307–310.

    Article  PubMed  CAS  Google Scholar 

  60. Chen, J., Birkholtz, G., Lindblom, P., Rubio, C., and Lindblom, A. (1998) The role of ataxia-telangiectasia heterozygotes in familial breast cancer. Cancer Res. 58: 1376–1379.

    PubMed  CAS  Google Scholar 

  61. Krontiris, T., Devlin, B., Karp, D., Robert, N., and Risch, N. (1993) An association between the risk of cancer and mutations in the HRAS1 minisatellite locus. N. Engl. J. Med. 329: 517–523.

    Article  PubMed  CAS  Google Scholar 

  62. Garrett, P., Hulka, B., Kim, Y., and Farber, R. (1993) HRAS protooncogene polymorphism and breast cancer. Cancer Epidemiol. Biomarkers Prevent. 2: 131–138.

    CAS  Google Scholar 

  63. Hall, J., Huey, B., Morrow, J., Newman, B., Lee, M., Jones, E., et al. (1990) Rare HRAS alleles and susceptibility to human breast cancer. Genomics 6: 188–191.

    Article  PubMed  CAS  Google Scholar 

  64. Rebbeck, T., Couch, F., Kant, J., Calzone, K., Deshano, M., Peng, Y., et al. (1996) Genetic heterogeneity in hereditary breast cancerz: role of BRCAI and BRCA2. Am. J. Human Genet. 59: 547–553.

    CAS  Google Scholar 

  65. Ambrosone, C. B. and Shields, P. G. (1997) Molecular epidemiology of breast cancer. In: Etiology of Breast and Gynecological Cancers, vol. 396 ( Aldaz, C.M., Gould, M.N., McLachlan, J. and Slaga, T. J., rds), Wiley-Liss, New York, pp. 83–99.

    Google Scholar 

  66. Helzlsouer, K., Selmin, O., Huang, H., Strickland, P., Hoffman, S., Alberg, A., et al. (1998) Associate between glutathione 5-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J. Natl. Cancer Inst. 90: 512–518.

    Article  PubMed  CAS  Google Scholar 

  67. Brunet, J., Ghadirian, P., Rebbeck, T., Lerman, C., Garber, J., Tonin, P., et al. (1998) Effect of smoking on breast cancer in carriers of mutant BRCA 1 or BRCA2 genes. J. Natl. Cancer Inst. 90: 761–766.

    Article  PubMed  CAS  Google Scholar 

  68. Devilee, P. and Cornelisse C. (1994) Somatic genetic changes in human breast cancer. Biochim. Biophys. Acta I198: 113–130.

    Google Scholar 

  69. Thompson, F., Emerson, J., Dalton, W., Yang, J.-M., McGee, D., Villar, H., et al. (1993) Clonal chromosome abnormalities in human breast carcinomas I. Twenty-eight cases with primary disease. Genes Chromosomes Cancer 7: 185–193.

    Article  PubMed  CAS  Google Scholar 

  70. Dutrillaux, B., Gerbault-Seureau, M. and Zafrani, B. (1990) Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes. Cancer Genet. Cytogenet. 49: 203–217.

    Article  PubMed  CAS  Google Scholar 

  71. Pandis, N., Heim, S., Bardi, G., Idvall, I., Mandahl, N., and Mitelman, F. (1992) Whole-arm t(1;16) and i(1 q) as sole anomalies identify gain of 1 q as a primary chromosomal abnormality in breast cancer. Genes Chromosomes Cancer 5: 235–238.

    Article  PubMed  CAS  Google Scholar 

  72. Kallioniemi, A., Kallioniemi, 0.-P., Sudar, D., Rutovitz, D., Gray, J., Waldman, F., et al. (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818–820.

    Article  PubMed  CAS  Google Scholar 

  73. Kallioniemi, A., Kallioniemi, 0.-P., Piper, J., Tanner, M., Stokke, T., Chen, L., et al. (1994) Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. Natl. Acad. Sci. USA 91: 2156–2160.

    Article  PubMed  CAS  Google Scholar 

  74. Gray, J., Collins, C., Henderson, I., Isola, J., Kallioniemi, A., Kallioniemi, 0.-P., et al. (1994) Molecular cytogenetics of human breast cancer. Cold Spring Harbor Symp. Quant. Biol. 59: 645–652.

    Article  PubMed  CAS  Google Scholar 

  75. Isola, J., Kallioniemi, O., Chu, L., Fuqua, S., Hilsenbeck, S., Osborne, C., et al. (1995) Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am. J. Pathol. 147: 905–911.

    PubMed  CAS  Google Scholar 

  76. Venter, D. J., Tuzi, N. L., Kumar, S., and Gullick, W. J. (1987) Overexpression ofthe c-erbB-2 oncoprotein in human breast carcinomas: Immunohistological assessment correlates with gene amplification. Lancet 2: 69–72.

    Article  PubMed  CAS  Google Scholar 

  77. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., et al. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707–712.

    Article  PubMed  CAS  Google Scholar 

  78. Berger, M., Locher, G., Saurer, S., Gullick, W., Waterfield, M., Groner, B. et al. (1988) Correlation of C-ERBB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res. 48: 1238–1243.

    PubMed  CAS  Google Scholar 

  79. Zhou, D., Battifora, H., Yokota, J., Yamamoto, T., and Cline, M. (1987) Association of multiple copies of the c-erbb-2 oncogene with spread of breast cancer. Cancer Res. 47: 6123–6125.

    PubMed  CAS  Google Scholar 

  80. Ravdin, P. and Chamness, G. (1995) The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers: a review. Gene 159: 19–27.

    Article  PubMed  CAS  Google Scholar 

  81. Aldaz, C., Chen, T., Sahin, A., Cunningham, J., and Bondy, M. (1995) Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas. Cancer Res. 55: 3976–3981.

    PubMed  CAS  Google Scholar 

  82. Muss, H. B., Thor, A. D., Berry, D. A., Kute, T., Liu, E. T., Koerner, F., et al. (1994) c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N. Engl. J Med. 330: 1260–1266.

    Google Scholar 

  83. Leitzel, K., Teramoto, Y., Konrad, K., Chinchilli, V. M., Volas, G., Grossberg, H., et al. (1995) Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer. J. Clin. Oncol. 13: 1129–1135.

    PubMed  CAS  Google Scholar 

  84. Muller, W., Sinn, E., Pattengale, P., Wallace, R., and Leder, P. (19881 Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54: 105–115.

    Google Scholar 

  85. Petit, A., Rak, J., Hung, M., Rockwell, P., Goldstein, N., Fendly, B., et al. (1997) Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vive: angiogenic implications for signal transduction therapy of solid tumors. Am. J. Pathol. 151: 1523–1530.

    Google Scholar 

  86. Wright, M., Grim, J., Deshane, J., Kim, M., Strong, T., Siegal, G., et al. (1997) An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2. Gene Ther. 4: 317–322.

    Article  PubMed  CAS  Google Scholar 

  87. Eccles, S., Court, W., Box, G., Dean, C., Melton, R., and Springer, C. (1994) Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185. Cancer Res. 54: 5171–5177.

    PubMed  CAS  Google Scholar 

  88. Baselga, J., (2001) Clinical trials of Herceptin (trastuzumab). Eur. J Cane. 37: 518–524.

    Google Scholar 

  89. Sandgren, E. P., Luetteke, N. C., Palmiter, R. D., Brinster, R. L., and Lee, D. C. (1990) Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61: 1121–1135.

    Article  PubMed  CAS  Google Scholar 

  90. Cohen. B. D., Siegall, C. B., Bacus, S., Foy, L., Green, J. M., Hellstrom, I., et al. (1998) Role of epidermal growth factor receptor family members in growth and differentiation of breast carcinoma. Biochem. Soc. Symp. 63: 199–210.

    Google Scholar 

  91. Visscher, D., Wallis, T., Awussah, S., Mohamed, A., and Crissman, J. (1997) Evaluation of MYC and chromosome 8 copy number in breast carcinoma by interphase cytogenetics. Genes Chromosomes Cancer 18: 1–7.

    Article  PubMed  CAS  Google Scholar 

  92. Chin, L., Liegeois, N., DePinho, R., and Schreiber-Agus, N. (1996) Functional interactions among members of the Myc superfamily and potential relevance to cutaneous growth and development. J. Invest. Dermatol. Symp. Proc. 1: 128–135.

    CAS  Google Scholar 

  93. White, E. (1996) Life, death and the pursuit of apoptosis. Genes Dey. 10: 1–15.

    Article  CAS  Google Scholar 

  94. Alexandrow, M. G., Kawabata, M., Aakre, M., and Moses, H. L. (1995) Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects oftransforming growth factor beta 1. Proc. Natl. Acad. Sci. USA 92: 3239–3243.

    Article  PubMed  CAS  Google Scholar 

  95. Evan, G. and Littlewood, T. (I 993) The role of c-myc in cell growth. Curr. Opin. Genet. Dev. 3: 44–49.

    Google Scholar 

  96. Shi, Y., Glynn, J., Guilbert, L., Cotter, T., Bissonnette, R., and Green, D. (1992) Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257: 212–214.

    Article  PubMed  CAS  Google Scholar 

  97. Steiner, P., Rudolph, B., Muller, D., and Eilers, M. (1996) The functions of Myc in cell cycle progression and apoptosis. Prog. Cell Cycle Res. 2: 73–82.

    Article  PubMed  CAS  Google Scholar 

  98. Leder, A., Pattengale, P., Kuo, A., Stewart, T., and Leder, P. (1986) Consequences of widspread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell 45: 485–495.

    Article  PubMed  CAS  Google Scholar 

  99. Varley, J., Swallow, J., Brammar, W., Whittaker, J., and Walker, R. (1987) Alterations to either C-ERBB-2 (NEU) or C-MYC protooncogenes in breast carcinomas correlate with poor short-term prognosis. Oncogene 1: 423–430.

    PubMed  CAS  Google Scholar 

  100. Shiu, R., Watson, P., and Dubik (1993) c-myc oncogene expression in estrogen-dependent and independent breast cancer. Clin. Chem. 39: 353–355.

    Google Scholar 

  101. Lammie, G. and Peters, G. (1991) Chromosome 11q13 abnormalities in human cancer. Cancer Cells 3: 413–420.

    PubMed  CAS  Google Scholar 

  102. Gillett, C., Fantl, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., et al. (1994) Amplification and overexpression ofcyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 54: 1812–1817.

    PubMed  CAS  Google Scholar 

  103. Bartkova, J., Lukas, J., Muller, H., Lutzhft, D., Strauss, M., and Bartek, J. (1994) Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer 57: 353–361.

    Article  PubMed  CAS  Google Scholar 

  104. Sicinski, P., Donaher, J. L., Parker, S., Li, T., Fazeli, A., Gardner, H., et al. (1995) Cyclin D1 provides a link between development and oncogenes in the retina and breast. Cell 82: 621–630.

    Article  PubMed  CAS  Google Scholar 

  105. Wang, T., Cardiff, R., Zukerberg, L., Lees, E., Arnold, A., and Schmidt, E. (1994) Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669–671.

    Article  PubMed  CAS  Google Scholar 

  106. Weinstat-Saslow, D., Merino, M., Manrow, R., Lawrence, J., Bluth, R., Wittenbel, K., et al. (1995) Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from nonmalignant lesions. Nature Med. 1 :1257–1260.

    Google Scholar 

  107. Muller, W., Lee, F., Dickson, C., Peters, G., Pattengale, P., and Leder, P. (1990) The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J. 9: 907–913.

    PubMed  CAS  Google Scholar 

  108. Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X. Y., et al. (1997) AIB 1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277: 965–968.

    Google Scholar 

  109. Knudson, A. (1971) Mutation and cancer: statistical study ofretinoblastoma. Proc. Natl. Acad. Sci. USA 68: 820–823.

    Article  PubMed  Google Scholar 

  110. Comings, D. (1973) A general theory ofcarcinogenesis. Proc. Natl. Acad. Sci. USA 70: 3324–3328.

    Article  PubMed  CAS  Google Scholar 

  111. Goodrich, D. and Lee, W.-H. (1993) Molecular characterization of the retinoblastoma susceptibility gene. Biochim. Biophys. Acta 1155: 43–61.

    PubMed  CAS  Google Scholar 

  112. Cox, L., Chen, G., and Lee, E. Y.-H. P. (1994) Tumor suppressor genes and their roles in breast cancer. Breast Cancer Res. Treat. 32: 19–38.

    Article  PubMed  CAS  Google Scholar 

  113. Weber, J. and May, P. (1989) Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am. J. Human Genet. 44: 388–396.

    CAS  Google Scholar 

  114. Hudson, T. J., Stein, L. D., Gerety, S. S., Ma, J., Castle, A. B., Silva, J., et al. (1995) An STS-based map of the human genome. Science 270: 1945–1954.

    Article  PubMed  CAS  Google Scholar 

  115. Brenner, A. and Aldaz, C. (1995) Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells. Cancer Res. 55: 2892–2895.

    PubMed  CAS  Google Scholar 

  116. Trent, J., Yang, J.-M., Emerson, J., Dalton, W., McGee, D., Massey, K., et al. (1993) Clonal chromosome abnormalities in human breast carcinomas II. Thirty-four cases with metastatic disease. Genes Chromosomes Cancer 7: 194–203.

    Article  PubMed  CAS  Google Scholar 

  117. Radford, D., Fair, K., Phillips, N., Ritter, J., Steinbrueck, T., Holt, M., et al. (1995) Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. Cancer Res. 55: 3399–3405.

    PubMed  CAS  Google Scholar 

  118. Fujii, H., Marsh, C., Cairns, P., Sidransky, D., and Gabrielson, E. (1996) Genetic divergence in the clonal evolution of breast cancer. Cancer Res. 56: 1493–1497.

    Google Scholar 

  119. Radford, D., Fair, K., Thompson, A., Ritter, J., Holt, M., Steinbrueck, T., et al. (1993) Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast. Cancer Res. 53: 2947–2949.

    PubMed  CAS  Google Scholar 

  120. Done, S., Arneson, N., Ozcelik, H., Redston, M., and Andrulis, I. (1998) p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias. Cancer Res. 58: 785–789.

    Google Scholar 

  121. Ozbun, M. and Butel, J. (1995) Tumor suppressor p53 mutations and breast cancer: a critical analysis. Adv. Cancer Res. 66: 71–141.

    Article  PubMed  CAS  Google Scholar 

  122. Donehower, L., Godley, L., Aldaz, C., Pyle, R., Shi, Y., Pinkel, D., et al. (1995) Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev. 9: 882–895.

    Article  PubMed  CAS  Google Scholar 

  123. Cornelis, R., van Vliet, M., Vos, C., Cleton-Jansen, A.-M., van de Vijver, M., Peterse, J., et al. (1994) Evidence fora gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cancer Res. 54: 4200–4206.

    PubMed  CAS  Google Scholar 

  124. Hall, J., Lee, M., Newman, B., Morrow, J., Anderson, L., Huey, B., et al. (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684–1689.

    Article  PubMed  CAS  Google Scholar 

  125. Futreal, P., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., et al. (1994) BRCA 1 mutations in primary breast and ovarian carcinomas. Science 266: 120–122.

    Article  PubMed  CAS  Google Scholar 

  126. Leone, A., McBride, O., Weston, A., Wang, M., Anglard, P., Cropp, C., et al. (1991) Somatic allelic deletion of nm23 in human cancer. Cancer Res. 51: 2490–2493.

    PubMed  CAS  Google Scholar 

  127. Cropp, C., Lidereau, R., Leone, A., Liscia, D., Cappa, A., Campbell, G., et al. (1994) NME1 protein expression and loss ofheterozygosity mutations in primary human breast tumors. J. Natl. Cancer Inst. 86: 1167–1169.

    Article  PubMed  CAS  Google Scholar 

  128. Borg, A., Zhang, Q.-X., Alm, P., Olsson H., and Sellberg, G. (1992) The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Cancer Res. 52: 2991–2994.

    PubMed  CAS  Google Scholar 

  129. Miki, Y., Katagiri, T., Kasumi, F., Yoshimoto, T., and Nakamura, Y. (1996) Mutation analysis in the BRCA2 gene in primary breast cancers. Nature Genet. 13: 245–247.

    Article  PubMed  CAS  Google Scholar 

  130. Teng, D., Bogden, R., Mitchell, J., Baumgard, M., Bell, R., Berry, S., et al. (1996) Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nature Genet. 13: 241–244.

    Article  PubMed  CAS  Google Scholar 

  131. Lancaster, J. M., Wooster, R., Mangion, J., Phelan, C. M., Cochran, C., Gumbs, C., et al. (1996) BRCA2 mutations in primary breast and ovarian cancers. Nature Genet. 13: 238–240.

    Article  PubMed  CAS  Google Scholar 

  132. Schott, D., Chang, J., Deng, G., Kurisu, W., Kuo, W., Gray, J., et al. (1994) A candidate tumor suppressor gene in human breast cancers. Cancer Res. 54: 1393–1396.

    PubMed  CAS  Google Scholar 

  133. Sato, T., Tanigami, A., Yamakawa, K., Akiyama, F., Kasumi, F., Sakamoto, G., et al. (1990) Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res. 50: 7184–7189.

    PubMed  CAS  Google Scholar 

  134. Tsuda, H., Callen, D., Fukutomi, T., Nakamura, Y., and Hirohashi, S. (1994) Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancer irrespectively of differences in phenotype and extent of spread. Cancer Res. 54: 513–517.

    PubMed  CAS  Google Scholar 

  135. Cleton-Jansen, A., Moerland, E., Kuipers-Dijkshoorn, N., Callen, D., Sutherland, G., Hansen, B., et al. (1994) At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Genes Chromosomes Cancer 9: 101–107.

    Article  PubMed  CAS  Google Scholar 

  136. Berx, G., Cleton-Jansen, A., Nollet, F., de Leeuw, W., van de Vijver, M., Cornelisse, C., et al. (1995) E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBOJ. 14: 6107–6115.

    CAS  Google Scholar 

  137. Yoshiura, K., Kanai, Y., Ochiai, A., Shimoyama, Y., Sugimura, T., and Hirohashi, S. (1995) Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. USA 92: 7416–7419.

    Article  PubMed  CAS  Google Scholar 

  138. Rimm, D., Sinard, J., and Morrow, J. (1995) Reduced a-catenin and E-cadherin expression in breast cancer. Lab. Invest. 72: 506–512.

    PubMed  CAS  Google Scholar 

  139. Lee, S. (1996) H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nature Med. 2: 776–782.

    Article  PubMed  CAS  Google Scholar 

  140. Bedmarck, A. K., Laflin, K. J., Daniel, K. J., Lino, Q., Hawkins, K. A., Aldez, C. M. (2000) WWOX, a novel WWdomain, containing protein mapping to human chomosome 16a 23.3–24.1 a region frequently affected in breast cancer. Cancer Res. 60: 2140–2145.

    Google Scholar 

  141. Kamb, A., Gruis, N., Weaver-Feldhaus, J., Qingyun, L., Harshman, K., Tavtigian, S., et al. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436–440.

    Article  PubMed  CAS  Google Scholar 

  142. Brenner, A., Paladugu, A., Wang, H., Olopade, O., Dreyling, M., and Aldaz, C. (1996) Preferential loss of expression of p16INK4a rather than p19ARF in breast cancer. Clin. Cancer Res. 2: 1993–1998.

    PubMed  CAS  Google Scholar 

  143. Altucci, L., Addeo, R., and Cicatiello, L. (1996) 1713-estradiol induces cyclin D1 gene transcription, p36D 1-p34cdk4 complex activation and plO5Rb phosphorylation during mitogenic stimulation of G1-arrested human breast cancer cells. Oncogene 12: 2315–2324.

    Google Scholar 

  144. Sherr, C. (1994) G1 phase progression: cycling on cue. Cell 79: 551–555.

    Article  PubMed  CAS  Google Scholar 

  145. Sherr, C. (1996) Cancer cell cycles. Science 274: 1672–1677.

    Article  PubMed  CAS  Google Scholar 

  146. Hui, R., Cornish, A., Mcclelland, R., Robertson, J., Blarney, R., Musgrove, E., et al. (1996) Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer. Clin. Cancer Res. 2: 923–928.

    PubMed  CAS  Google Scholar 

  147. Graybablin, J., Zalvide, J., Fox, M., Kinckerbocker, C., Decaprio, J., and Keyomarsi, K. (1996) Cyclin E, a redundant cyclin in breast cancer. Proc. Natl. Acad. Sci. USA 93: 15215–15220.

    Article  CAS  Google Scholar 

  148. Porter, P., Malone, K., Heagerty, P., Alexander, G., Gatti, L., Firpo, E., et al. (1997) Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med. 3: 222–225.

    Article  PubMed  CAS  Google Scholar 

  149. Varley, J., Armour, J., Swallow, J., Jeffreys, A., Ponder, B., T’Ang, A., et al. (1989) The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours. Oncogene 4: 725–729.

    PubMed  CAS  Google Scholar 

  150. Okamoto, A., Demetrick, D., Spillare, E., Hagiwara, K., Hussain, S., Bennett, W., et al. (1994) Mutations and altered expression of p 16INK4 in human cancer. Proc. Natl. Acad. Sci. USA 91: 11045–11049.

    Article  PubMed  CAS  Google Scholar 

  151. Parry, D., Bates, S., Mann, D., and Peters, G. (1995) Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p161NK4/MTS1 tumour suppressor product. EMBO J. 14: 503–511.

    PubMed  CAS  Google Scholar 

  152. Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366: 701–704.

    Google Scholar 

  153. Waga, S., Hannon, G., Beach, D., and Stillman, B. (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574–578.

    Article  PubMed  CAS  Google Scholar 

  154. Brugarolas, J., Chandrasekaran, C., Gordon, J., Beach, D., Jacks, T., and Hannon, G. (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552–557.

    Article  PubMed  CAS  Google Scholar 

  155. Pomerantz, J., Schreiber-Agus, N., Liegeois, N., Silverman, A., Alland, L., Chin, L., et al. (1998) The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53. Cell 92: 713–723.

    Article  PubMed  CAS  Google Scholar 

  156. Zhang, Y., Xiong, Y., and Yarbrough, W. G. (1998) ARF promotes MDM2 degradation and stablizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92: 725–734.

    Article  PubMed  CAS  Google Scholar 

  157. Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., et al. (1998) p14ARF links the tumour suppressors RB and p53. Nature 395: 124–125.

    Google Scholar 

  158. Oltvai, Z., Milliman, C., and Korsmeyer, S. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, accelerates programmed cell death. Cell 74: 609–619.

    Article  PubMed  CAS  Google Scholar 

  159. Joensuu, H., Pylkkanen, L., and Toikkanen, S. (1994) Bcl-2 protein expression and long-term survival in breast cancer. Am. J. Pathol. 145: 1191–1198.

    PubMed  CAS  Google Scholar 

  160. Barbareschi, M., Caffo, O., Veronese, S., Leek, R., Fina, P., Fox, S., et al. (1996) Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up. Human Pathol. 27: 1149–1155.

    Article  CAS  Google Scholar 

  161. Sierra, A., Castellsague, X., Coll, T., Manas, S., Escobedo, A., Moreno, A., et al. (1998) Expression of death-related genes and their relationship to loss of apoptosis in T1 ductal breast carcinomas. Int. J. Cancer 79: 103–110.

    Article  PubMed  CAS  Google Scholar 

  162. Beatson, G. (1896) On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases. Lancet ii:104–107.

    Google Scholar 

  163. Fishman, J., Osborne, M., and Telang, N. (1995) The role of estrogen in mammary carcinogenesis. Ann. NY Acad. Sci. 768: 91–100.

    Article  PubMed  CAS  Google Scholar 

  164. Tsai, M. and O’Malley, B. (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Ann. Rev. Biochem. 63: 451–486.

    Article  PubMed  CAS  Google Scholar 

  165. Leung, B. and Potter, A. (1987) Mode of estrogen action on cell proliferation in CAMA-1 cells: II. Sensitivity of GI phase population. J. Cell. Biochem. 34: 213–225.

    Article  PubMed  CAS  Google Scholar 

  166. Davidson, N., Prestigiacomo, L., and Hahm, H. (1993) Induction of jun gene family members by transforming growth factor alpha but not 17 beta-estradiol in human breast cancer cells. Cancer Res. 53: 291–297.

    PubMed  CAS  Google Scholar 

  167. Prall, O., Sarcevic, B., Musgrove, E., Watts, C., and Sutherland, R. (1997) Estrogen-induced activation of Cdk4 and Cdk2 during GlSphase progression is accompanied by increased cyclin D 1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J. Biol. Chem. 272: 10882–10894.

    Article  PubMed  CAS  Google Scholar 

  168. Zwijsen, R., Wientjens, E., Klompmaker, R., van der Sman, J., Bernards, R., and Michalides, R. (1997) CDK-independent activation of estrogen receptor by cyclin D1. Cell 88: 405–415.

    Article  PubMed  CAS  Google Scholar 

  169. Zhang, L., Zhou, W., Velculescu, V., Kern, S., Hruban, R., Hamilton, S., et al. (1997) Gene expression profiles in normal and cancer cells. Science 276: 1268–1272.

    Article  PubMed  CAS  Google Scholar 

  170. Perov, C. M., Soulie, T., Eisen, M. B., van de Kijin, M., Jeffrey, S. S., Rees, C. A., et al. (2000) Molecular portraits of human breast tumors. Nature 406. 747–752.

    Article  Google Scholar 

Download references

Authors
  1. April Charpentier PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Marcelo Aldaz MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA

    William B. Coleman

  2. Department of Pathology and Laboratory Medicine, Hartford Hospital, Hartford, CT, USA

    Gregory J. Tsongalis

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Charpentier, A., Aldaz, C.M. (2002). The Molecular Basis of Breast Carcinogenesis. In: Coleman, W.B., Tsongalis, G.J. (eds) The Molecular Basis of Human Cancer. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-125-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-125-1_15

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-107-3

  • Online ISBN: 978-1-59259-125-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation